The FDA gave the OK for the North Chicago-based medical device maker's Tendyne transcatheter mitral valve replacement.

The system is available for patients whose mitral valves are not working properly due to severe mitral annular calcification.

The Thermostatic Mixing Valve Market is projected to grow from USD 1,202.40 million in 2024 to USD 1,749.6 million by 2032, ...

Wireless condition monitoring network pinpoints troublesome valves and steam traps, reducing emissions by the equivalent of ...

The FDA approved Abbott's Tendyne minimally invasive heart replacement for mitral valve disease that could disqualify ...

Abbott (NYSE: ABT) announced today that it received FDA approval for its Tendyne transcatheter mitral valve replacement (TMVR ...

Looking toward approval in the US, larger studies with careful hemodynamic data will be needed, says Martin Leon.

This week, a number of companies, big and small, shared updates on their cardiovascular technology innovations at EuroPCR ...

Sanitube’s sanitary steel products are an essential link in the supply chain that gets milk, cheese, and other foods to your ...

Abbott (NYSE: ABT) today announced the U.S. Food and Drug Administration (FDA) has approved the company's Tendyne™ transcatheter mitral valve replacement (TMVR) system to treat people with mitral ...

They call it a money shift because making this mistake with your manual transmission can cost you big bucks. But what does it ...

If you're doing a bathroom renovation or just want to understand your plumbing better, you should know how to tell which kind ...